Reviance Press Releases
October 16, 2012
Mesa, Ariz. — Oct. 16, 2012 — Ulthera, Inc. — a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology — today unveiled its new Ulthera System software upgrade, Ultherapy Amplify, which is now commercially available in the U.S. in new Systems and is currently being rolled out to existing Ulthera customers at no charge.
The System upgrade integrates new treatment guidelines for its cosmetic lifting procedure updated to improve patient comfort without impacting efficacy, and to reflect treatment best practices. Also included is a more visual, intuitive user-interface, which allows practitioners to navigate through the procedure more efficiently.
“This is a significant enhancement to the System that reflects our continued commitment to responding to the needs of our physician customers and their patients,” said Matthew Likens, president and CEO of Ulthera. “We are happy to say that Ultherapy Amplify addresses the critical factors of comfort, efficiency and optimizing outcomes, all the while ensuring the treatment’s reputation for safety is maintained.”
“Physicians can rest assured that when they purchase our System, Ulthera will continue to add value to their investment during each year of ownership, whether it be through a no-charge software upgrade, new clinical indications, additional transducers or enhanced marketing support,” Likens continued. “In fact, on the heels of this System upgrade, Ulthera also will be launching a U.S. advertising initiative to help spread the word about our progressive Ultherapy treatment, and we are aggressively pursuing more clinical indications as evidenced by the recent FDA clearance for the device to lift tissue on the neck and under the chin.”
Ulthera, Inc. is a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ultherapy.com.
Réviance® Portland to donate portion of profits to Clackamas Women’s Services
By Julianna Schneider
October 1, 2012
Portland, Oregon – In honor of National Domestic Violence Awareness Month, you can help support local women who are survivors of domestic violence while enjoying an age-reversing non-surgical treatment through Project LIFT.
Dr. James Chan’s facial plastic surgery and aesthetic practice, Reviance Portland® Portland, announced a cross-promotional partnership today with Clackamas Women’s Services in Oregon that will result in financial and service donations to benefit survivors of domestic violence.
“We are excited that Dr. Chan is choosing to support CWS and hope that our partnership will raise awareness for women in our area facing domestic and sexual violence. We want the community to know that we offer a safe place for survivors to find support and affirmation as they strive to become violence-free and self-sufficient,” said Executive Director Melissa Erlbaum.
New and established patients of Reviance Portland® Portland can help support women who are victims of domestic and sexual violence when they elect to receive an Ultherapy Treatment, as a portion of all treatment proceeds are earmarked for Clackamas Women’s Services (CWS).
Double board-certified facial plastic surgeon, James Chan, MD, specializes in facial plastic and reconstructive surgery and will donate a portion of Ultherapy treatment sales in October as part of his commitment to support CWS as part of his Project LIFT campaign, a program created to drive charitable contributions to help survivors of domestic violence. Ultherapy is the first and only FDA-approved non-surgical treatment to lift facial skin.
“Working with Clackamas Women’s Services through Project LIFT is a meaningful way for us at Reviance Portland® Portland to support women who have faced domestic violence and give them the encouragement they need to face a new life with greater self-esteem,” said Dr. Chan. “We are honored to be part of the effort to foster self-empowerment of women so they can establish lives free of domestic violence.”
Project LIFT campaign hopes proceeds and subsequent treatments will “lift” the spirits and lives of the women it supports. Dr. Chan and Reviance Portland® Portland plan to continue partnership work with CWS after October to offer other services and treatments to select CWS clients as part of an ongoing, supportive commitment.
Ultherapy treatment proceeds that benefit Clackamas Women’s Services are available through the month of October at Reviance Portland® Portland located at 9200 SE 91st Avenue, Suite 210, Portland, OR 97086. More information can be found at: http://revianceportland.com/ More information about Clackamas Women’s Services can be found at http://www.cwsor.org/about_us.htm
Julianna Schneider, AOR for Reviance Portland® Portland